Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cocco

Showing results (161-170 of 191) with videos related to

Pageof 20
Sort By:
Current Medicinal Chemistry|June 9, 2011
Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in cancer stem cellsA M Martelli, C Evangelisti, M Y Follo, et al.
Leukemia|April 16, 2004
Inositide-specific phospholipase c beta1 gene deletion in the progression of myelodysplastic syndrome to acute myeloid leukemiaV R Lo Vasco, G Calabrese, L Manzoli, et al.
Biochimica Et Biophysica Acta|April 13, 2000
Identification and chromosomal localisation by fluorescence in situ hybridisation of human gene of phosphoinositide-specific phospholipase C beta(1)D Peruzzi, G Calabrese, I Faenza, et al.
Leukemia|February 20, 2003
Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulationR Bortul, P L Tazzari, A Cappellini, et al.
Leukemia|September 13, 2003
A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cellsA M Martelli, P L Tazzari, G Tabellini, et al.
Journal of Submicroscopic Cytology|October 1, 1983
Association between centriole and nuclear matrix in human lymphocytesN M Maraldi, F Marinelli, S Amati, et al.
Advances in Enzyme Regulation|January 1, 1990
Nuclear inositol lipids. Relationship between growth factor induced metabolic changes and protein kinase C activityL Cocco, S Capitani, A M Martelli, et al.
Journal of Endocrinological Investigation|December 14, 1999
Independent expression of serological markers of thyroid autoimmunity and hepatitis virus C infection in the general population: results of a community-based study in north-western SardiniaA Loviselli, A Oppo, F Velluzzi, et al.
FEBS Letters|December 20, 2000
Insulin selectively stimulates nuclear phosphoinositide-specific phospholipase C (PI-PLC) beta1 activity through a mitogen-activated protein (MAP) kinase-dependent serine phosphorylationA M Martelli, A M Billi, L Manzoli, et al.
Leukemia|November 27, 2010
Synergistic induction of PI-PLCβ1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromesM Y Follo, C Finelli, S Mongiorgi, et al.
Pageof 20

Showing results (161-170 of 191) with videos related to

Sort By:
Pageof 20
Current Medicinal Chemistry|June 9, 2011
Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in cancer stem cellsA M Martelli, C Evangelisti, M Y Follo, et al.
Leukemia|April 16, 2004
Inositide-specific phospholipase c beta1 gene deletion in the progression of myelodysplastic syndrome to acute myeloid leukemiaV R Lo Vasco, G Calabrese, L Manzoli, et al.
Biochimica Et Biophysica Acta|April 13, 2000
Identification and chromosomal localisation by fluorescence in situ hybridisation of human gene of phosphoinositide-specific phospholipase C beta(1)D Peruzzi, G Calabrese, I Faenza, et al.
Leukemia|February 20, 2003
Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulationR Bortul, P L Tazzari, A Cappellini, et al.
Leukemia|September 13, 2003
A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cellsA M Martelli, P L Tazzari, G Tabellini, et al.
Journal of Submicroscopic Cytology|October 1, 1983
Association between centriole and nuclear matrix in human lymphocytesN M Maraldi, F Marinelli, S Amati, et al.
Advances in Enzyme Regulation|January 1, 1990
Nuclear inositol lipids. Relationship between growth factor induced metabolic changes and protein kinase C activityL Cocco, S Capitani, A M Martelli, et al.
Journal of Endocrinological Investigation|December 14, 1999
Independent expression of serological markers of thyroid autoimmunity and hepatitis virus C infection in the general population: results of a community-based study in north-western SardiniaA Loviselli, A Oppo, F Velluzzi, et al.
FEBS Letters|December 20, 2000
Insulin selectively stimulates nuclear phosphoinositide-specific phospholipase C (PI-PLC) beta1 activity through a mitogen-activated protein (MAP) kinase-dependent serine phosphorylationA M Martelli, A M Billi, L Manzoli, et al.
Leukemia|November 27, 2010
Synergistic induction of PI-PLCβ1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromesM Y Follo, C Finelli, S Mongiorgi, et al.
Pageof 20